跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
MONOFERRIC - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
MONOFERRIC
Authorized
STANDARD
MONOFERRIC
Pharmacosmos A/S
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
bd26c195d021d23c
Company
Pharmacosmos A/S
Type
Standard
Approval Details
Approval Id
bd26c195d021d23c
Drug Approval Canada Name
MONOFERRIC
Product Name
MONOFERRIC
Status
Marketed
Status Date
2022-01-14
Original Market Date
2018-10-17
Din
02477777
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Intravenous
Schedule
Prescription
Ahfs
20:04.04
Atc Original
B03AC IRON, PARENTERAL PREPARATIONS
Atc Name
b 03 ac
Aig Number
0108536004
Company Name
Pharmacosmos A/S
Company Address
Roervangsvej 30, Holbaek, --, Denmark, 4300
Company Detail Path
/organization/pharmacosmos-a-s
Company Information
Pharmaceutical Company Name
Pharmacosmos A/S
Country Name
Denmark
Province Name
sjælland,country_dk
City Name
holbæk,sjælland,country_dk
Address
Rørvangsvej 30
Website
http://www.pharmacosmos.com
Active Ingredients
IRON (FERRIC DERISOMALTOSE)
100 MG / ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
bd26c195d021d23c
Type
Standard
Back to Health Canada Approvals